Fortive Inkomsten in het verleden
Verleden criteriumcontroles 4/6
De winst van Fortive is gedaald met een gemiddeld jaarlijks percentage van -16.8%, terwijl de winst van de Machinery -industrie jaarlijks groeide met 8%. De inkomsten zijn daalde met een gemiddeld percentage van 2.5% per jaar. Het rendement op het eigen vermogen Fortive bedraagt 9.1% en de nettomarge bedraagt 13.1%.
Belangrijke informatie
-16.77%
Groei van de winst
-16.57%
Groei van de winst per aandeel
| Machinery Groei van de industrie | 8.77% |
| Inkomstengroei | -2.48% |
| Rendement op eigen vermogen | 9.14% |
| Nettomarge | 13.14% |
| Laatste winstupdate | 03 Apr 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • May 20
FTV: Buybacks And Sequential Execution Will Support Future Earnings Quality
Fortive's analyst price target has been raised by several firms in recent research, collectively edging higher by single digits in dollar terms. Analysts point to solid sequential growth and recent company execution to support slightly higher revenue growth and P/E expectations, even as profit margin assumptions are trimmed and the discount rate is nudged up.Narratiefupdate • May 02
FTV: Sterilization Demand And Buybacks Will Support Future Earnings Quality
Fortive's analyst fair value estimate has been nudged up by $1 to $73 after analysts weighed a mix of recent price target increases and trims alongside recalibrated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Fortive shows a mix of target price trims and increases, with bullish analysts generally leaning toward higher fair value assumptions even as some recalibrate their models.
Narratiefupdate • Apr 16
FTV: Future P E Compression Will Challenge Buyback Support At Current Levels
Fortive's analyst price targets have seen a mixed reset, with one firm trimming its view by $7 while several others lifted their targets by $4 to $9, as analysts factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on Fortive shows a mix of optimism and caution, with several firms lifting their price targets and one trimming its view by $7.Seeking Alpha • Apr 14
Fortive: Starting To Improve Its Performance
Summary Fortive has executed well post-Ralliant spin-off, delivering solid earnings and modest organic growth, supporting a fair valuation. Fortive's 2025 sales rose 2% to $4.16B, with 4Q organic growth exceeding 3%; adjusted EPS reached $2.71, up $0.30 YoY. Guidance targets 2026 adjusted EPS of $2.90–$3.00, underpinned by 2–3% organic growth, margin gains, and continued buybacks. At 19–20x forward earnings and leverage in the mid-2s, Fortive offers reasonable value, though upside is capped without stronger growth catalysts. Read the full article on Seeking AlphaNarratiefupdate • Apr 02
FTV: Fair Value View Balances Buybacks Against Execution And P E Compression Risks
Analysts have nudged their fair value estimate for Fortive higher to $52.50 from $51.10, reflecting updated views on revenue growth, margins, and future P/E assumptions following a mix of recent price target hikes and one downgrade across the Street. Analyst Commentary Recent Street research on Fortive shows a mixed but generally cautious tone, with a cluster of price target increases alongside at least one downgrade and a later price target cut.Narratiefupdate • Mar 19
FTV: Fair Value Case Weighs Buybacks Against Execution And Multiple Compression Risks
Fortive's analyst price target has been adjusted slightly lower to $51.10. Analysts point to updated fair value estimates, refined discount rate assumptions, and refreshed views on revenue growth, margins, and future P/E multiples following a series of recent price target revisions across major firms.Narratiefupdate • Mar 05
FTV: North American Sterilization Demand Will Support Future Earnings Quality Upside
Analysts have lifted their price targets on Fortive, supporting a move in our fair value estimate from $66.00 to $72.00. They cited updated expectations for revenue growth, profitability and a lower forward P/E multiple.
Narratiefupdate • Feb 19
FTV: Recent Rating Shift And Buybacks Will Shape Future Return Profile
Our updated Fortive narrative reflects a higher implied price target of about $62, as analysts factor in steadier revenue growth assumptions, slightly stronger profit margins, a modestly lower discount rate, and a similar forward P/E, consistent with a series of recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of higher Fortive price targets, alongside at least one downgrade.Narratiefupdate • Feb 04
FTV: JPMorgan Downgrade And Buybacks Will Shape A Measured Return Profile
Analysts have trimmed their price target on Fortive to US$58.13, citing a slightly lower discount rate, modestly softer revenue expectations and a higher assumed profit margin supported by a reduced future P/E multiple. Analyst Commentary Recent commentary around the new US$58.13 price target reflects a mixed view on Fortive, with the latest JPMorgan downgrade underlining both execution opportunities and areas of concern for valuation and growth.Narratiefupdate • Jan 21
FTV: Balanced Outlook As Healthcare Demand And Buybacks Shape Future Returns
Narrative Update The analyst price target for Fortive has shifted from approximately $56.13 to $58.13, as analysts cite recent model updates and sequential improvements in North American demand for sterilization and biomedical equipment, along with higher AHS adjusted EBITDA driven by gross profit growth and lower costs. Analyst Commentary Recent research on Fortive reflects a mix of optimism on execution and caution around upside potential, which is showing up in both price target changes and rating shifts.Narratiefupdate • Jan 06
FTV: Fair Value View Balances Higher Demand With Margin Execution Risks
Analysts have increased their fair value estimate for Fortive from US$50.00 to US$52.00, citing refreshed models after the Q3 report and Street research that points to improved North American demand for sterilization and biomedical equipment, stronger AHS adjusted EBITDA margins, and updated price targets clustered around US$55 to US$58. Analyst Commentary Recent Street research on Fortive points to updated price targets clustered in the US$55 to US$58 range, with analysts revising their models following the Q3 report.Analyseartikel • Dec 27
Estimating The Fair Value Of Fortive Corporation (NYSE:FTV)
Key Insights The projected fair value for Fortive is US$53.12 based on 2 Stage Free Cash Flow to Equity Current share...Narratiefupdate • Dec 15
FTV: North American Sterilization Demand Will Support Earnings Quality And Upside Potential
Analysts have modestly raised their blended price target on Fortive to about $58 per share from roughly $55, citing improved North American demand for sterilization and biomedical equipment, stronger margins in Advanced Healthcare Solutions, and updated post earnings financial models that still reflect slightly softer long term growth and profitability assumptions. Analyst Commentary Bullish analysts are pointing to a constructive risk reward profile for Fortive, highlighting that incremental execution gains and healthier end market trends can support the recent step up in valuation.Narratiefupdate • Oct 20
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered their fair value estimate for Fortive to $56.13 from $57.25. They cite a tougher outlook and more challenging revenue growth projections for the remainder of the year.Narratiefupdate • Sep 18
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive's price target to $57.25 due to skepticism over the company's ability to meet guidance amid slowing growth in its strongest segment, caution around macro headwinds post-Ralliant spinoff, and minimal near-term revenue growth. Analyst Commentary Persistent skepticism regarding Fortive's ability to achieve its full-year guidance following a cautious update and lack of supportive industry data.Narratiefupdate • Sep 03
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive’s target price to $60.50, citing uncertainty about achieving updated guidance following the Ralliant spin-off, ongoing topline and margin pressures, and diminished visibility post-restructuring. Analyst Commentary Bullish analysts highlight Fortive's high earnings visibility and strong recurring revenue profile (~50%+), expecting portfolio reviews and strategic focus on workflow management software and healthcare to support margin resilience.Analyseartikel • May 30
A Look At The Intrinsic Value Of Fortive Corporation (NYSE:FTV)
Key Insights Fortive's estimated fair value is US$88.69 based on 2 Stage Free Cash Flow to Equity Fortive's US$71.07...Seeking Alpha • Mar 10
Fortive Seeing Signs Of Improvement, But Valuation Doesn't Make It An Easy Call
Summary Fortive's fourth-quarter results (and full 2024 results) showed fairly ordinary performance, with revenue and margins missing targets, and the business model didn't meaningfully outperform peers through the cycle. 2025 should be a better year, and I'd expect Fortive's businesses to recover ahead of more manufacturing and machinery-focused peers. The upcoming split of Precision Technologies into Ralliant may reduce complexity but is unlikely to significantly add or destroy value, but I can see potential strategic bidders for Tektronix. Despite cautious optimism for 2025, FTV's valuation doesn't justify a premium, given its inability to outgrow inflation and deliver superior full-cycle performance. Read the full article on Seeking AlphaSeeking Alpha • Dec 11
Fortive Corporation: Undervaluation And Stability Give It An Edge (Rating Upgrade)
Summary Fortive Corporation's product innovations and increased bookings, particularly in cloud-based solutions, support a recovery by 2025 despite macro uncertainties delaying short-term growth. The company’s strong cash flow, robust liquidity, and undervaluation compared to peers justify an upgrade to a "Buy" rating. Fortive's solid balance sheet, aggressive share repurchase policy, and stable cash flow position it well for superior medium-term returns. Read the full article on Seeking AlphaSeeking Alpha • Sep 22
Fortive: A Softer Performance Triggers A Separation
Summary Fortive is a solid conglomerate operating in three segments, focusing on intelligent operating solutions, precision technologies and healthcare solutions. After a softer performance of the precision technologies business this year, the company has announced plans to separate the business. The company trades at reasonable valuations and leverage, with a potential for higher valuation post-separation, expected to complete by Q4 2025. I recommend initiating positions in the $70s or high $60s, as the business separation may drive significant shareholder value. Read the full article on Seeking AlphaOpbrengsten en kosten
Opbrengsten en kosten
Hoe Fortive geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 03 Apr 26 | 4,235 | 557 | 1,670 | 262 |
| 31 Dec 25 | 4,159 | 533 | 1,661 | 259 |
| 26 Sep 25 | 6,260 | 885 | 2,185 | 421 |
| 27 Jun 25 | 6,237 | 879 | 2,165 | 421 |
| 28 Mar 25 | 3,550 | 388 | 1,498 | 211 |
| 31 Dec 24 | 4,081 | 483 | 1,651 | 251 |
| 27 Sep 24 | 4,592 | 555 | 1,774 | 285 |
| 28 Jun 24 | 5,083 | 661 | 1,870 | 322 |
| 29 Mar 24 | 6,129 | 900 | 2,119 | 402 |
| 31 Dec 23 | 3,914 | 408 | 1,667 | 237 |
| 29 Sep 23 | 6,012 | 828 | 2,025 | 400 |
| 30 Jun 23 | 5,973 | 800 | 2,012 | 403 |
| 31 Mar 23 | 5,910 | 764 | 1,983 | 403 |
| 31 Dec 22 | 5,826 | 755 | 1,956 | 402 |
| 30 Sep 22 | 5,671 | 696 | 1,943 | 393 |
| 01 Jul 22 | 5,516 | 659 | 1,907 | 380 |
| 01 Apr 22 | 5,372 | 650 | 1,878 | 368 |
| 31 Dec 21 | 5,255 | 580 | 1,842 | 355 |
| 01 Oct 21 | 5,205 | 1,646 | 1,747 | 345 |
| 02 Jul 21 | 5,064 | 1,562 | 1,727 | 337 |
| 02 Apr 21 | 4,786 | 1,440 | 1,700 | 326 |
| 31 Dec 20 | 4,634 | 1,383 | 1,732 | 321 |
| 25 Sep 20 | 2,556 | -147 | 1,246 | 212 |
| 26 Jun 20 | 3,256 | -26 | 1,377 | 252 |
| 27 Mar 20 | 4,079 | 90 | 1,486 | 292 |
| 31 Dec 19 | 4,564 | 199 | 1,582 | 320 |
| 27 Sep 19 | 7,075 | 718 | 2,058 | 454 |
| 28 Jun 19 | 6,816 | 724 | 1,932 | 439 |
| 29 Mar 19 | 6,553 | 816 | 1,800 | 423 |
| 31 Dec 18 | 3,800 | 455 | 1,221 | 278 |
| 28 Sep 18 | 5,602 | 837 | 1,522 | 378 |
| 29 Jun 18 | 5,686 | 909 | 1,463 | 376 |
| 30 Mar 18 | 5,713 | 899 | 1,415 | 373 |
| 31 Dec 17 | 5,756 | 884 | 1,378 | 369 |
| 29 Sep 17 | 6,476 | 932 | 1,438 | 397 |
| 30 Jun 17 | 6,359 | 891 | 1,409 | 390 |
| 31 Mar 17 | 6,285 | 890 | 1,402 | 387 |
| 31 Dec 16 | 5,378 | 740 | 1,264 | 351 |
| 30 Sep 16 | 6,173 | 884 | 1,352 | 377 |
| 01 Jul 16 | 6,130 | 854 | 1,347 | 377 |
| 01 Apr 16 | 6,140 | 842 | 1,331 | 376 |
| 31 Dec 15 | 6,179 | 864 | 1,334 | 378 |
| 02 Oct 15 | 6,290 | 857 | 1,392 | 384 |
Kwaliteitswinsten: FTV heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (13.1%) FTV } zijn hoger dan vorig jaar (11.3%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van FTV is de afgelopen 5 jaar met 16.8% per jaar gedaald.
Versnelling van de groei: De winstgroei van FTV over het afgelopen jaar ( 32.5% ) overtreft het 5-jarig gemiddelde ( -16.8% per jaar).
Winst versus industrie: De winstgroei FTV over het afgelopen jaar ( 32.5% ) overtrof de Machinery -sector 1.6%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 9.1% ) van FTV wordt als laag beschouwd.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/22 05:46 |
| Aandelenkoers aan het einde van de dag | 2026/05/22 00:00 |
| Inkomsten | 2026/04/03 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Fortive Corporation wordt gevolgd door 29 analisten. 15 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| John Eade | Argus Research Company |
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |